Nadege Pelletier's most recent trade in Barinthus Biotherapeutics Plc. - ADR was a trade of 105,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Barinthus Biotherapeutics ... | Nadege Pelletier | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 105,000 | 105,000 | - | - | Share Option (Right to Buy) |